Skip to main content
. 2017 Apr 26;2017(4):CD010770. doi: 10.1002/14651858.CD010770.pub2

NCT00882258.

Methods Randomised controlled trial
Participants Premenopausal women with fibroids
Interventions Telapristone acetate 12.5 mg vs 25 mg vs placebo
Outcomes Unclear
Notes Protocol NCT00882258 in clinicaltrials.gov of telapristone acetate 12.5 mg vs 25 mg vs placebo. No results in database nor in published literature. States trial was completed